Is ibogaine legal?

United States: Schedule I

Ibogaine has been a Schedule I controlled substance under the federal Controlled Substances Act since the early 1970s, the most restrictive category, defined as having no accepted medical use and a high abuse potential. No US state has legalized ibogaine treatment. That means clinical use inside the US is limited to authorized research, and bringing ibogaine into the country is illegal. This is the legal reality that sends patients to Mexico.^[1]

Mexico: unscheduled, not "approved"

Ibogaine is not a scheduled substance under Mexican law, which is why clinics can administer it openly without operating underground. But unscheduled is not the same as approved: COFEPRIS, Mexico's health regulator, has not endorsed ibogaine as a medicine, and there is little formal oversight of the clinics themselves. That regulatory gap is exactly why independent verification of a clinic's safety practices matters so much, since no regulator is doing it for you.

What changed in 2025 and 2026

The US policy picture is shifting faster than it has in decades, though none of it has legalized treatment yet:

• Texas IMPACT trial (Dec 2025): Texas committed $50 million to fund FDA-track clinical trials of ibogaine for PTSD, addiction and cognitive trauma, the largest public investment to date.^[2]
• Federal executive order (April 18 2026): an order on accelerating treatments for serious mental illness directed the FDA and DEA to speed psychedelic research and establish a Right-to-Try access pathway, with roughly $50 million in federal support.^[3] It does not reschedule ibogaine, which remains Schedule I.
• State activity: multiple states introduced ibogaine research or access bills in 2025, per policy trackers.^[4]

The direction is toward research access, not open legality. If you are waiting for a legal US route, the honest answer is that it does not exist yet, though a trial pathway is the most likely first door.